Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial . (16th September 2021)
- Record Type:
- Journal Article
- Title:
- Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial . (16th September 2021)
- Main Title:
- Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial
- Authors:
- Osborne-Grinter, Maia
Kwiecinski, Jacek
Doris, Mhairi
McElhinney, Priscilla
Cadet, Sebastien
Adamson, Philip D
Moss, Alastair J
Alam, Shirjel
Hunter, Amanda
Shah, Anoop S V
Mills, Nicholas L
Pawade, Tania
Wang, Chengjia
Weir-McCall, Jonathan R
Roditi, Giles
van Beek, Edwin J R
Shaw, Leslee J
Nicol, Edward D
Berman, Daniel
Slomka, Piotr J
Newby, David E
Dweck, Marc R
Dey, Damini
Williams, Michelle C - Abstract:
- Abstract: Aims: Coronary artery calcification is a marker of cardiovascular risk, but its association with qualitatively and quantitatively assessed plaque subtypes is unknown. Methods and results: In this post-hoc analysis, computed tomography (CT) images and 5-year clinical outcomes were assessed in SCOT-HEART trial participants. Agatston coronary artery calcium score (CACS) was measured on non-contrast CT and was stratified as zero (0 Agatston units, AU), minimal (1–9 AU), low (10–99 AU), moderate (100–399 AU), high (400–999 AU), and very high (≥1000 AU). Adverse plaques were investigated by qualitative (visual categorization of positive remodelling, low-attenuation plaque, spotty calcification, and napkin ring sign) and quantitative (calcified, non-calcified, low-attenuation, and total plaque burden; Autoplaque) assessments. Of 1769 patients, 36% had a zero, 9% minimal, 20% low, 17% moderate, 10% high, and 8% very high CACS. Amongst patients with a zero CACS, 14% had non-obstructive disease, 2% had obstructive disease, 2% had visually assessed adverse plaques, and 13% had low-attenuation plaque burden >4%. Non-calcified and low-attenuation plaque burden increased between patients with zero, minimal, and low CACS ( P < 0.001), but there was no statistically significant difference between those with medium, high, and very high CACS. Myocardial infarction occurred in 41 patients, 10% of whom had zero CACS. CACS >1000 AU and low-attenuation plaque burden were the onlyAbstract: Aims: Coronary artery calcification is a marker of cardiovascular risk, but its association with qualitatively and quantitatively assessed plaque subtypes is unknown. Methods and results: In this post-hoc analysis, computed tomography (CT) images and 5-year clinical outcomes were assessed in SCOT-HEART trial participants. Agatston coronary artery calcium score (CACS) was measured on non-contrast CT and was stratified as zero (0 Agatston units, AU), minimal (1–9 AU), low (10–99 AU), moderate (100–399 AU), high (400–999 AU), and very high (≥1000 AU). Adverse plaques were investigated by qualitative (visual categorization of positive remodelling, low-attenuation plaque, spotty calcification, and napkin ring sign) and quantitative (calcified, non-calcified, low-attenuation, and total plaque burden; Autoplaque) assessments. Of 1769 patients, 36% had a zero, 9% minimal, 20% low, 17% moderate, 10% high, and 8% very high CACS. Amongst patients with a zero CACS, 14% had non-obstructive disease, 2% had obstructive disease, 2% had visually assessed adverse plaques, and 13% had low-attenuation plaque burden >4%. Non-calcified and low-attenuation plaque burden increased between patients with zero, minimal, and low CACS ( P < 0.001), but there was no statistically significant difference between those with medium, high, and very high CACS. Myocardial infarction occurred in 41 patients, 10% of whom had zero CACS. CACS >1000 AU and low-attenuation plaque burden were the only predictors of myocardial infarction, independent of obstructive disease, and 10-year cardiovascular risk score. Conclusion: In patients with stable chest pain, zero CACS is associated with a good but not perfect prognosis, and CACS cannot rule out obstructive coronary artery disease, non-obstructive plaque, or adverse plaque phenotypes, including low-attenuation plaque. Graphical Abstract: … (more)
- Is Part Of:
- European heart journal. Volume 23:Number 9(2022)
- Journal:
- European heart journal
- Issue:
- Volume 23:Number 9(2022)
- Issue Display:
- Volume 23, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 23
- Issue:
- 9
- Issue Sort Value:
- 2022-0023-0009-0000
- Page Start:
- 1210
- Page End:
- 1221
- Publication Date:
- 2021-09-16
- Subjects:
- coronary calcium score -- low-attenuation plaque -- computed tomography -- computed tomography coronary angiography -- atherosclerotic plaque
Cardiovascular system -- Imaging -- Periodicals
Heart -- Imaging -- Periodicals
616.10754 - Journal URLs:
- http://ehjcimaging.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/ehjci/jeab135 ↗
- Languages:
- English
- ISSNs:
- 2047-2404
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22913.xml